The Vaccine Innovation Prioritisation Strategy (VIPS) is a collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH to evaluate and prioritize vaccine product innovations for low- and l...

PATH is excited to announce the 7th International Conference on Microneedles will be held May 15 through 17, 2023, in Seattle, Washington. This in-person conference will bring together researchers, scientists, public health leaders, and industry experts from across the globe focused...

Many thanks for attending the session on measles and rubella microarray patches. Follow the URL below to see the session in case you have missed it:  https://www.youtube.com/watch?v=wAcQx5SI6c8 Below I summarise key discussion points from the session:  • The few remaining countries that...

Dear Technet community, Hope you’re well. I’d like to share a short article I wrote (published on May 15) making the case to immediately start planning for COVID-19 immunization delivery and suggesting activities to focus on now. The article focuses on India, but the core points and suggestions fo...

Dear measles and rubella vaccine delivery and implementation experts, WHO is soliciting your expertise on the potential need and use for microarray patches (MAPs) (otherwise known as microneedles or microneedle patches) to deliver measles and rubella vaccines (MR), particularly in the context of ex...

Hello all, Microarray patches (MAPs) are under development for delivering vaccine into the skin. The technology has exciting potential for application to immunization programs. PATH is looking for input from experts in low- and middle-income country immunization programs about the feasibility of M...